Stress Cardiac MRI for Evaluation of Nonspecific Allograft Dysfunction

PHASE4CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Heart TransplantAcute Graft RejectionChronic Graft Rejection
Interventions
DRUG

Regadenoson

For use in stress myocardial perfusion imaging.

DRUG

Gadolinium

For use in both perfusion imaging and late gadolinium enhancement.

PROCEDURE

Cardiac MRI

Cardiac MRI will be the imaging modality for perfusion imaging, late gadolinium enhancement and obtaining mean T1 segmental values of the heart.

Trial Locations (1)

92037

UC San Diego, La Jolla

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Astellas Pharma Inc

INDUSTRY

lead

Paul Kim

OTHER